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ABSTRACT
Objective To evaluate the effects of a multifaceted
empowermentstrategyontheactualuseofsingleembryo
transfer after in vitro fertilisation.
Design Randomised controlled trial.
SettingFiveinvitrofertilisationclinicsintheNetherlands.
Participants 308 couples (women aged <40) on the
waiting list for a first in vitro fertilisation cycle.
Interventions The multifaceted strategy aimed to
empower couples in deciding how many embryos should
be transferred. The strategy consisted of a decision aid,
supportofanursespecialisingininvitrofertilisation,and
the offer of reimbursement by way of an extra treatment
cycle.Thecontrolgroupreceivedstandardcareforinvitro
fertilisation.
Main outcome measures Use of single embryo transfer in
the first and second treatment cycles as well as decision
makingvariablesandcostsoftheempowermentstrategy.
Results After the first treatment cycle, single embryo
transfer was used by 43% (65/152) of couples in the
interventiongroupand32%(50/156)inthecontrolgroup
(difference 11%, 95% confidence interval 0% to 22%;
P=0.05). After the second treatment cycle, single embryo
transfer was used by 26% (14/154) of couples in the
intervention group compared with 16% (8/51) in the
control group (difference 10%, −6% to 26%; P=0.20).
Compared with couples receiving standard care, those
receiving the empowerment strategy had significantly
higher empowerment and knowledge levels but no
differences in anxiety levels. Mean total savings per
couple in the intervention group were calculated to be
€169.75 (£146.77; $219.12).
Conclusions A multifaceted empowerment strategy
encouraged use of single embryo transfer, increased
patients’ knowledge, reduced costs, and had no effect on
levels of anxiety or depression. This strategy could
therefore be an important tool to reduce the twin
pregnancyrate afterin vitrofertilisation.Thistrialdidnot,
however, demonstrate the anticipated 25% difference in
use of single embryo transfer of the power calculation.
Trial registration ClinicalTrials.gov NCT00315029.
INTRODUCTION
Empowering patients is essential for good medical
decision making and has been mentioned as an essen-
tial characteristic of good quality care.
1-3 Patient
empowerment implies a process of informing patients
and providing them with the necessary tools and
autonomy to adopt an active role in decision making.
It is supposed to ensure that patients’ experiences and
opinions are integrated into clinical decisions, as well
as to encourage doctors and researchers to focus on
patient centred outcomes.
4 However, the effect of
patientempowerment,especiallywithincomplexdeci-
sionmakingprocesses,isstillbeingdebated.Concerns
were raised that patients might decline responsibility
for decision making or that they would choose subop-
timal or most expensive options.
56
An example of a complex and important decision
makingproblemisthenumberofembryostransferred
after in vitro fertilisation. The transfer of only one
embryo will prevent a multiple pregnancy with the
associated complications for the mother and
neonates.
7-9 Single embryo transfer may also be disad-
vantageous,however,becausedoubleembryotransfer
results in higher live birth rates per treatment cycle
(odds ratio 2.1, 95% confidence interval 1.7 to 2.7
8).
Therefore, compared with the transfer of multiple
embryos, single embryo transfer could imply a neces-
sityformorecyclestoachievepregnancy.
10-12Thisbal-
ance between the risk for complications of multiple
birthsandoptimalchanceof pregnancycreatesa com-
plex decision making problem. Although profes-
sionals and policy makers have launched initiatives to
encouragetheuseofsingleembryotransfer,
13ithasnot
been successfully implemented in clinical practice. In
2004, the European multiple pregnancy rate after in
vitro fertilisation was still 23%, and single embryo
transfer was used in only 19% of all cycles.
14
Lack ofknowledgeaboutthe prosandcons ofsingle
embryo transfer and the costs of the potentially neces-
sary additional cycles are important barriers for use
of single embryo transfer.
15-17 On the basis of these
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empower couples for the decision about the number
of embryos transferred. This strategy consisted of an
evidence based decision aid, support of an in vitro fer-
tilisation nurse, and reimbursement of an additional
cycle for couples for whom the decision for single
embryo transfer caused a reduced chance of preg-
nancy. We evaluated the effects of this multifaceted
empowerment strategy on the actual number of
embryos transferred, the impact on the decision
making process, and costs related to the strategy.
METHODS
In the Netherlands, in vitro fertilisation (including
intracytoplasmic sperm injection) is carried out in 13
licensed hospitals: eight university hospitals, four gen-
eral hospitals, and one private clinic. In hospitals with-
out a licence, professionals can start up and monitor in
vitro fertilisation but refer to a licensed hospital for the
retrieval of oocytes and embryo transfer. The current
averagepregnancyrateperinvitrofertilisationcyclein
the Netherlands is about 24%.
18 Most couples who do
not achieve pregnancy after a first cycle undergo suc-
cessive cycles. The Dutch national healthcare system
reimbursesthe costs ofthe firstthreecycles, butonly if
amaximumoftwoembryosaretransferred.Beforethe
start of this trial, it was standard practice in the partici-
pating centres that couples and their doctor shared the
decision making process between single or double
embryo transfer. Pros and cons of both options were
discussed and similar neutral information was avail-
able for couples on the department’s website. By then
(2005) 39% of the couples underwent single embryo
transfer after the first cycle.
19
Design, participants, and sample size
The randomised controlled trial was designed to test
the hypothesisthat a multifaceted empowermentstrat-
egy could encourage the use of single embryo transfer
and reduce the number of twin pregnancies in a cost
effective way. We compared the empowerment strat-
egy in addition to standard practice for in vitro fertili-
sation with standard practice only.
Our randomised controlled trial was carried out in
two licensed hospitals and three associated clinics and
included couples on the waiting list for in vitro fertilisa-
tionbetweenNovember2006andJuly2007.Follow-up
was continued until December 2008. The couples pro-
vided written informed consent before participation.
The criteria for inclusion were couples on the wait-
inglistforafirstinvitrofertilisationcycleeverorafirst
cycle after previous successful in vitro fertilisation,
withthewomenyoungerthan40.Astrictmedicalindi-
cation for preventing twin pregnancies (anomalies of
the uterus, for example) made single embryo transfer
mandatory, and was therefore an exclusion criterion.
Randomisation took place centrally using a compu-
tergeneratedrandomisationlist.Participantswereran-
domised in blocks of four couples. A secretary outside
our department was the only person with access to the
randomisation list. She randomised the couples on the
dayconsentwasreceivedandinformedthecouplethat
same day. Because of the nature of the intervention it
was not possible to blind the participants or in vitro
fertilisation doctors to the allocation. Participation in
ourtrialdidnotchangethenormalinvitrofertilisation
routine.
Wedeterminedthattodetecta25%differenceinuse
of single embryo transfer between the groups com-
pared with the baseline of 39%, with an α of 0.05, two
sided testing, and a power of 0.80, we needed at least
123 couples eligible for analysis. However, because
participants were included and randomised before
the treatment began, not all couples started with in
vitro fertilisation (for instance, because of a sponta-
neouspregnancyorendingoftherelationship).Taking
these potential reasons for dropout into account, we
aimed for about 300 couples for inclusion.
Interventions
The control group received standard in vitro fertilisa-
tion care, including a session in which the number of
embryos transferred was discussed. In addition to this
standardcare,theinterventiongroupreceivedamulti-
faceted empowerment strategy. The elements of the
strategy were sent by post, because use of the internet
oremailcouldhavemadeelementsoftheintervention
available to the control group. Couples in the inter-
vention group were sent a decision aid, developed at
our department, about the number of embryos trans-
ferred (available in English at www.umcn.nl/ivfda-en
Table 1 |Characteristics of participating couples; intention to treat population. Values are
numbers (percentages) unless stated otherwise
Characteristics
Intervention group
(n=152)
Control group
(n=156)
Previous successful IVF/ICSI treatment 23/152 (15) 25/156 (16)
Mean (SD) age of woman (years) 32.0 (3.9) 31.7 (4.2)
Mean (SD) duration of infertility (years) 2.2 (1.8) 2.3 (2.0)
Primary infertility 99/152 (65) 102/156 (65)
IVF 69/136 (51) 61/135 (45)
ICSI 67/136 (49) 74/135 (55)
Diagnostic categories of infertility:
Male factor 83/143 (58) 102/149 (69)
Unexplained 36/143 (25) 20/149 (13)
Endometriosis 7/143 (5) 9/149 (6)
Tubal factor 10/143 (7) 10/149 (7)
Other 7/143 (5) 8/131 (5)
Educational level:
High school or less 3/148 (2) 4/156 (3)
Vocational education 21/148 (14) 26/156 (17)
Pre-college or graduate education 63/148 (43) 63/156 (40)
Completed college or graduate 61/148 (41) 63/156 (40)
Monthly income (€):
1100 to 1760 4/150 (3) 2/155 (1)
1760 to 2750 19/150 (13) 28/155 (18)
>2750 106/150 (71) 106/155 (68)
Decided not to tell 21/150 (13) 19/155 (13)
€1.00 (£0.85; $1.23).
IVF=in vitro fertilisation; ICSI=intracytoplasmic sperm injection.
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20 This deci-
sion aid was developed according to the checklist of
theInternationalPatientDecisionAidsStandardsCol-
laboration. This checklist consists of 50 items divided
over three domains (content, development, and effec-
tiveness). Examples of topics on this checklist are
unbiased selection of options, presentation of content,
methods of clarifying personal values, evaluation of
the developmental process, and quality of decision
making.
21 The couples also received the offer of reim-
bursementofanadditionalfourthcycle.Thisreimbur-
sement was applicable only if couples chose single
embryo transfer in the first and second cycle and no
pregnancy occurred. Subsequently, the content of the
decision aid and the reimbursement offer were dis-
cussed in person with a trained in vitro fertilisation
nurse. These three elements of the strategy were all
provided before the counselling session that is part of
standard care. The last element of the strategy was a
telephone call from the nurse just before pick up of
the oocytes to discuss any questions that might have
arisenduringtreatment.Seethewebextraforagraphi-
cal depiction of the multifaceted intervention.
Outcome measures
The primary outcome was the actual use of single or
double embryo transfer in the first and second cycles.
Secondary outcomes were those related to pregnancy,
variables of the decision making process (for example,
empowerment, decisional conflict), levels of anxiety,
depression, and cost evaluation of the empowerment
strategy.Fromthelocalinvitrofertilisationregistrywe
collected data on the number of embryos transferred,
background characteristics (woman’s age, primary or
secondary infertility, duration of infertility, and cause
of infertility), and the outcomes of the in vitro fertilisa-
tion cycles. We used validated questionnaires com-
pleted by the women to measure the decision making
outcomes. The participants received the first question-
naire at inclusion to the study, a second after the inter-
vention (but before starting treatment), and the third
five weeks after the embryo transfer. We used the
general self efficacy scale to obtain levels of
empowerment.
22 Experienced knowledge levels were
measured with self grading. Actual knowledge was
measured using an 11 item multiple choice test. We
monitored decision evaluation scores by means of a
15 item questionnaire, which included three domains;
satisfaction/uncertainty, informed choice, and deci-
sion control.
23 We determined anxiety and depression
levels with the state trait anxiety inventory
24 and the
Beck depression inventory.
25
We evaluated the costs associated with implementa-
tionoftheempowermentstrategyinclinicalinvitrofer-
tilisation practice. This was done from a healthcare
perspective and determined the difference in total
costs per couple between groups. We included all the
costs for couples in the intervention group, including
those couples who discontinued treatment. This expo-
sure was registered on an exposure form (one for every
specificcouple),whichwasfilledineachtimethecouple
underwentpartsoftheintervention.Wecalculatedcosts
onthe basisofactual exposure to the differentelements
of the strategy. We excluded protocol driven costs for
thisspecifictrial,includingthoseforthedevelopmentof
the decision aid. Costs included were those associated
with all elements of the intervention (printing and dis-
tributionofthedecisionaid,thenurse,andthereimbur-
sementoffer),aswellasthemedicalcostsassociatedwith
additionalcyclesnecessarytocompensateforreduction
inchanceofpregnancyasaresultofusingsingleembryo
transferandthemedicalcostsassociatedwiththediffer-
enceinfrequencyofsingletonandtwinpregnancies.For
intervention costs we determined print and postal costs
of the decision aid from actual expenses. Costs of
the nurse were based on training hours and timing of
the counselling sessions. Prices were determined from
guidelinesforcostrelatedresearchintheNetherlands.
26
Forthesurplusofcouplesintheinterventiongroupwho
underwent embryo transfer and did not achieve a preg-
nancy compared with these couples in the control
group, we calculated the costs for the additional cycles
on the assumption that couples needed an average of
1.5 cycles compensation after a failed first cycle and
one cycle compensation after a second failed cycle.
The couples in the intervention group who had chosen
single embryo transfer in the first and second cycle and
who did not achieve a pregnancy after three cycles in
total, qualified for reimbursement of a fourth cycle.
Thesecostswereincludedaswell.Fromapreviousana-
lysis at our department we determined the costs per
cycle and the medical costs (including antenatal care
and hospital admission from pregnancy to six weeks
after delivery) per singleton or twin pregnancy; a cycle
costing€2071, a singleton pregnancy €2788,and a twin
pregnancy €14727.
27 We adjusted all unit costs to 2008
Euros by using the consumer price index as published
by the Central Bureau of Statistics in the Netherlands
(http://statline.cbs.nl/statweb).
Statistical analysis
All analyses were carried out in the intention to treat
population. For both study groups we described the
Assigned to standard care (n=156)
Underwent embryo transfer (n=119) Underwent embryo transfer (n=117)
Assigned to standard care plus multifaceted
empowerment strategy (n=152)
Couples eligible for inclusion (n=344)
Randomised, intention to treat analysis (n=308)
Pregnant before treatment (n=9)
Never started treatment (n=4)
No embryo transfer; total fertilisation failure
    (n=22)
Pregnant before treatment (n=11)
Never started treatment (n=9)
No embryo transfer; total fertilisation failure
    (n=17)
Not randomised; already started in vitro fertilisaton by time of consent (n=36)
Trial profile
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 8use of single embryo transfer in the first and second
cycle, as well as the ongoing rates of pregnancy
(definedasaviablepregnancyof>12weeks’gestation)
and of twin pregnancy. These results included sponta-
neous pregnancies that occurred before the start of the
treatment. The χ
2 test was used to test for statistical dif-
ferences. We considered P values ≤0.05 to be signifi-
cant. To identify potential confounders for differences
in use of single embryo transfer we carried out multi-
variable regression analysis. We added the woman’s
age (years), presence of a good quality embryo (yes or
no), duration of infertility (years), and previous preg-
nancies (yes or no) to the model, with use of single
embryo transfer as the dependent variable. For the
empowerment scale, we dichotomised the original
five point Likert scale, combining the two categories
in which participants wanted to decide for themselves
asfullyempowered(wantingtomakethedecisionwith
the doctor only as adviser) and the other categories as
not fully empowered (wanting to make the decision
with the doctor as a decision maker as well). Experi-
enced and actual knowledge were expressed by
means and 95% confidence intervals. For each of the
three domains of the decision evaluation scale, we cal-
culated a sum score and presented the mean and 95%
confidence interval. We applied the same procedure
for the sum score to the anxiety and depression items.
Additionally,forthedepressionlevelwedichotomised
this sum score as 1 (no depression) and 2 (subclinical
depression) at a cut-off level of 4.
28 On this question-
naire a score of 4 or higher could imply the need for
psychological support, although a face to face inter-
view would be required to diagnose clinical depres-
sion. In addition to the tests on the differences
betweentheinterventionandcontrolgroups,wetested
the intervention group for differences in empower-
ment, experienced knowledge, anxiety, and depres-
sion levels from baseline to after the empowerment
strategy.Forthiscalculationweusedthepairedsample
t test for dichotomous variables and the Wilcoxon
signed rank test for continuous variables. We used
SPSS version 16.0.01 for the statistical analyses.
RESULTS
The figure shows the flow of the trial. Overall, 308 of
344 couples who provided written consentwererando-
mised; 36 couples had already started in vitro fertilisa-
tion. All 308 couples were included in the intention to
treat analysis. Table 1 shows the characteristics of the
couplesinthetwogroups.Norelevantdifferenceswere
observed between the groups. Seven couples in the
intervention group had spontaneous ongoing pregnan-
cies before the start of in vitro fertilisation compared
with nine couples in the control group. Moreover, four
couples in the intervention group never started treat-
ment compared with nine couples in the control
group. The reasons for quitting were diverse. After
oocyte retrieval and fertilisation, 236 couples had at
least one embryo available and underwent embryo
transfer. Thirty couples in the intervention group had
only one embryo available for transfer compared with
23 couples in the control group. For 188 couples this
treatment was the first ever in vitro fertilisation cycle.
Forty eight couples had undergone successful in vitro
fertilisation previously.
Effectiveness
Table 2 showsthe actual use of singleembryo transfer
and the number of ongoing and twin pregnancies after
the first cycle. In the intervention group 43% (65/152)
ofcoupleschosesingleembryotransfercomparedwith
32% (50/156) in the control group (difference 11%,
95% confidence interval 0% to 22%; P=0.05). Multi-
variable analysis showed that the odds ratio for this
11% difference did not change after addition of the
potential confounders, such as the woman’s age or
the presence of a good quality embryo. The difference
in use of singleembryotransferwas more pronounced
among the 48 couples who had previously undergone
in vitro fertilisation than the group of 188 couples who
were undergoing their first ever cycle: 64% (16/25) v
35% (8/23), P=0.04 compared with 53% (49/92) v 44%
(42/96).Thecontrolgrouphad11moreongoingpreg-
nancies than the intervention group (P=0.27) but also
fourmoretwinpregnancies(P=0.32).Intotal,105cou-
ples underwent a second cycle. In this second cycle,
single embryo transfer was used in 26% (14/54) of the
couples in the intervention group compared with 16%
(8/51) in the control group (difference 10%, −6% to
26%; P=0.20). After the second cycle the control
group had two more ongoing pregnancies than the
intervention group (17/51 (33%) v 15/54 (28%);
P=0.54) but two extra twin pregnancies as well (6/51
(12%) v 4/54 (7%); P=0.45).
Table 3 lists the variables related to patient empow-
ermentinbothgroups.Theproportionofcouplesinthe
intervention group who wanted to decide for them-
selves on the number of embryos transferred (with the
doctor as adviser only and not someone with influence
on the decision) increased from 77% (116/150) to 91%
(116/127), while this percentage remained 73%
(99/135) in the control group (P<0.001). Levels of
both experienced knowledge (P=0.001) and actual
knowledge (P<0.001) were higher in the intervention
group (n=123) compared with the control group
(n=132). The decision evaluation scale did not differ
significantlyinsatisfaction-uncertaintyorcontrollevels,
but couples in the intervention group (n=124) reported
a better informed choice compared with those in the
control group (n=128; P=0.01). This better informed
choice persisted until five weeks after embryo transfer
Table 2 |Single embryo transfer use and pregnancy outcomes after first in vitro fertilisation
cycle. Values are numbers (percentages) unless stated otherwise
First cycle
Intervention
group (n=152)
Control group
(n=156)
% difference
(95% CI) P value
No choosing single embryo transfer 65 (43) 50 (32) 11 (0 to 22) 0.05
Ongoing pregnancies* 48 (32) 59 (38) 6 (−4 to 17) 0.25
Twin pregnancies 6 (4) 10 (6) 2 (−3t o7 ) 0 . 3 3
Analyses in intention to treat population.
*>12 weeks’ gestation.
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anxiety levels. At uptake of in vitro fertilisation the fre-
quencyofsubclinical depressiondid not differbetween
the intervention and control group: 11% (16/147) v 9%
(113/151). After patients received the empowerment
strategy, however, this frequency was higher in the
intervention group (13% (16/126) v 4% (5/136);
P=0.01); this difference diminished after embryo trans-
fer, however (14% (17/123) v 14% (17/120); P=0.94).
Within the intervention group the proportion of fully
empowered couples increased significantly by 14%
from baseline to after the multifaceted intervention
(P=0.001) as did the level of experienced knowledge
(P<0.001). Anxietylevels orthe occurrence ofsubclini-
cal depression did not differ significantly.
Costs
Costs of the elements of the empowerment strategy
were added to the savings owing to a lower rate of
twin pregnancies. Table 4 shows the mean total costs
per couple, calculated in the intention to treat popula-
tion (n=152). Costs of the counselling session with the
nursewerebasedonanaveragedurationof29minutes
and less than two minutes for the telephone call. Six of
the 152 couples (4%) in the intervention group used
single embryo transfer in the first and second cycles
but failed to become pregnant after three cycles in
total. They therefore qualified for reimbursement
with a fourth cycle. After computing all costs of this
trial, the mean total savings in the intervention group
were calculated to be €169.75 per couple included
from the waiting list for in vitro fertilisation.
DISCUSSION
Patients seem willing and able to make complex deci-
sions if they are empowered. Although this trial did
not demonstrate the anticipated effect of the power
calculation, the multifaceted empowerment strategy
encouraged use of single embryo transfer and
increased patients’ knowledge. The strategy consisted
of a decision aid, support of an in vitro fertilisation
nurse, and an offer of reimbursement. The strategy
also significantly increased the empowerment level of
the couples in decision making about the number of
embryos transferred and increased actual and experi-
enced knowledge about important aspects of the deci-
sion. Levels of anxiety did not differ between couples
receiving the multifaceted intervention and those
receiving standard care for in vitro fertilisation. After
exposure to the empowerment strategy more subclini-
caldepressionwasobservedintheinterventiongroup.
This could imply that participants in the intervention
groupneededextrapsychologicalsupportafterreceiv-
ing the empowerment strategy. However, this differ-
ence diminished after embryo transfer, with an equal
percentage of subclinical depression in the inter-
vention and control groups. This effect on levels of
depression is probably caused by the outcome (failure
or success) of the treatment itself. Within this trial, the
strategy reduced costs, with an average of €169.75 per
couple.IfthesesavingswereextrapolatedtotheDutch
national level, with 7500 new couples per year, this
reduction would add up to €1273125 annually. With
national implementation, additional costs would be
expected—for example, costs related to keeping the
information up to date in the decision aid. However,
with broad implementation the printing and training
costs per couple would decrease noticeably and are
likely to at least compensate for these additional costs.
Comparison with other studies
Theresultsofthisstudyareinterestinginseveralways.
Firstly, they show that empowerment for couples
choosing in vitro fertilisation can lead to noticeable
effectsonthechoiceofnumberofembryostransferred.
Interestingly, this effect was stronger among couples
Table 3 |Decision making outcomes at baseline and after exposure to multifaceted intervention but before start of in vitro fertilisation (IVF)
Variables
Baseline After multifaceted intervention (before IVF)
Intervention group Control group P value Intervention group Control group P value
No of fully empowered couples 116/150 112/154
0.35
116/127 99/135
<0.001
% (95% CI) 77 (70 to 83) 73 (65 to 79) 91 (85 to 95) * 73 (65 to 80)
Mean knowledge (0-10)† (95% CI):
Experienced 5.7 (5.4 to 6.1) 5.8 (5.4 to 6.2) 0.72 7.7 (7.5 to 7.8)‡ 7.2 (7.0 to 7.4) 0.001
Actual —— — 6.2 (5.7 to 6.7) 4.3 (4.0 to 4.7) <0.001
Mean decision evaluation scale (1-5)† (95% CI):
Satisfaction-uncertainty —— — 3.9 (3.8 to 4.0) 4.0 (3.9 to 4.1) 0.76
Informed choice —— — 4.1 (4.0 to 4.2) 3.8 (3.7 to 3.9) 0.001
Control —— — 4.4 (4.3 to 4.5) 4.5 (4.4 to 4.5) 0.33
Anxiety level (20-80) 35.6 (33.9 to 37.3) 34.6 (33.1 to 36.1) 0.40 36.4 (34.7 to 38.2)§ 34.7 (33.3 to 36.1) 0.14
No with subclinical depression 16/147 13/151
0.51
16/126 5/136
0.01
% (95% CI) 11 (7 to17) 9 (5 to 14) 13 (8 to 20) ¶ 4( 1t o9 )
Analyses in intention to treat population.
*P value difference between baseline and after intervention 0.001.
†As specified on ClinicalTrials.gov (NCT00315029).
‡P value difference between baseline and after intervention <0.001.
§P value difference between baseline and after intervention 0.094.
¶P value difference between baseline and after intervention 0.439.
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coupleswhounderwenttheirfirsteverincycle.Aclear
differenceinoutcomewithanimplementationstrategy
solely for patients is rare.
2930 This may be because the
elementsofourstrategywerespecificallybasedonbar-
riersreportedbycouplesandprofessionalsinprevious
studies.
151619 The positiveresults ofthis studyare even
more remarkable when it is considered that profes-
sionals are still debating the necessity of preventing
twin pregnancies with single embryo transfer and
whether implementation of single embryo transfer
should be encouraged by way of legislation or
reimbursement.
153132 It could be claimed that empow-
ered couples might be more suitable to encourage the
use of single embryo transfer than professionals. Sec-
ondly,withtheempowermentstrategy,91%ofthecou-
ples wanted to decide for themselves the number of
embryos transferred (with their doctor as adviser
only). Once people have received proper support
they are apparently eager and capable of making
such complex decisions. Thirdly, we anticipated reim-
bursement to have a prominent role within the strat-
egy, but it did not. Many couples did not qualify for
reimbursement because they chose double embryo
transfer in the first or second cycle. Only 4% of the
couples (six of 152 couples in the intervention group)
qualified for reimbursement and to date only two cou-
ples have received a fourth cycle. Finally, the empow-
erment strategy was not designed to prevent twin
pregnancies but to support the decision making pro-
cess. Although this study shows a higher proportion
of couples deciding on single embryo transfer, at least
half of them still wanted to transfer two embryos after
thefirstcycle.However,wehavenoticedanincreasein
couples’ capabilitytomakeaninformeddecision.Per-
haps if couples are empowered to make this decision
andtocomprehendtheprosandconsofsingleembryo
transfer,thestrategyisalreadyasuccessandonecould
argue about the desirability of further encouragement
of single embryo transfer.
The setting in which the empowerment strategy is
usedisobviouslyimportant.Globally,invitrofertilisa-
tion is carried out in different contexts, which can
greatly influence the effects of our strategy. Some Eur-
opean countries implemented legislation prohibiting
the transfer of more than one embryo, or reimburse-
mentofsingleembryotransfercyclesonly.
33-35Inother
countries higher multiple pregnancy rates exist, as a
result of average higher numbers of embryos being
transferred.
14 The effects of this strategy can be differ-
entinthesediversesettings.Still,mostcountriesdonot
havecompulsorylegislationforsingleembryotransfer
and previous research has shown that even with such
legislation or reimbursement, total acceptance of sin-
gle embryo transfer was not achievable.
36 It is possible
thatthetwinningrateofourcontrolgroupiswellbelow
the European average. This is probably because in the
Netherlandsonlya maximumoftwoembryosistrans-
ferred and prevention of twin pregnancies is discussed
with all couples undergoing in vitro fertilisation. This
resultedinatwinrateofonly6%.Inothersettings,with
higher background rates for twins, the effects of our
empowerment strategy might be even more substan-
tial. A further difference could be the magnitude of
patientautonomywithintheprocessofshareddecision
making. Discrepancies between countries and even
clinics in how much say couples have are large. The
results of our strategy might be less pronounced in set-
tingswithlesspatientautonomythanourparticipating
centres. Different cultural and ethnic backgrounds of
couples undergoing in vitro fertilisation (for example,
desired family size) could also influence the effects of
the empowerment strategy. It would therefore be
interesting to observe the effects of our empowerment
strategy in different populations. A final important dif-
ferenceisthatDutchhealthinsurancereimbursesthree
in vitro fertilisation cycles. The results of the strategy
could be different in settings with fewer or no reim-
bursed cycles, especially as the absence of reimburse-
ment is an incentive to transfer more embryos.
17 But
even then we would expect educated couples, who
understand the risks of twin pregnancies, to be more
inclined to choose single embryo transfer.
Strengths and weaknesses of the study
Although our empowerment strategy was tailored for
the barriers identified by our previous research
151619
and the decision aid was developed according to the
evidence based criteria of the International Patient
Decision Aids Standards,
21 this study also has some
potential weaknesses. Firstly, from our initial power
calculation we assumed that we would obtain a differ-
ence in use of single embryo transfer of 25%. The 11%
(95% confidence interval 0% to 22%) difference
Table 4 |Costs of multifaceted patient empowerment strategy
per couple in in vitro fertilisation practice
Elements of costs
Costs per
couple* (€)
Elements of empowerment strategy
Decision aid:
Print costs 8.70
Postage costs 0.45
IVF nurse†:
Training (16 hours in total) 3.05
Counselling session 100.65
Telephone call 5.80
Reimbursement offer‡:
Reimbursed fourth cycles 81.75
Obstetrical cost reduction§ §
Six fewer twin pregnancies −581.35
Medical related costs
Extra cycles to compensate for loss in chance
of pregnancy after single embryo transfer use
211.20
Total savings 169.75
€1.00 (£0.85; $1.23).
*Total costs in intention to treat population (costs divided by 152
intervention group couples).
†Based on Oostenbrink 2004 et al.
23
‡Based on six couples that qualified for reimbursement (total costs €12
426).
§Based on fewer singleton and twin pregnancies after first and second
cycle in intervention group.
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remained below this pre-specified goal. However,
because of extensive evidence on the reduction of the
twin pregnancy rate to 0-1% with use of single embryo
transfer
7-9 compared with about 23% with double or
multiple embryo transfer,
14 the authors believe this
11% difference to be relevant for clinical practice. Sec-
ondly, the national basis of our strategy might limit
generalisability as Dutch professionals and couples
mayperceivebarriersthataredifferentfromthoseper-
ceived elsewhere. None the less, most of these barriers
are not specifically related to the Dutch setting, so that
the results of this study are probably valid for other
countries. Another potential weakness of our trial was
the time of follow-up. At present, not all couples have
finishedalltheircyclesanddonotknowhowtreatment
will turn out. Finally, it is difficult to assess separately
the effects of the different elements of the multifaceted
empowerment strategy. Although only 4% of the cou-
ples qualified for reimbursement of a fourth cycle,
reimbursement may have playeda part in the decision
making process.
Conclusions and implications
We infer from this study that patients are willing and
able to make complex decisions if they are empow-
ered, as long as they are provided with the correct
information, in an appropriate way, and in a setting
with patient autonomy. Implementation of this multi-
faceted empowerment strategy could also help profes-
sionals working in the specialty of in vitro fertilisation
as the strategy contributes to a more efficient decision
making process and a reduction in costs. More
research is welcomed to determine the effectiveness
of the empowerment strategy in other settings and to
evaluate which elements of the strategy contribute
most to its effectiveness. A potential weakness of this
trial could be that the 11% difference in use of single
embryo transfer (95% confidence interval 0% to 22%;
P=0.05) remained below the anticipated 25% differ-
ence of the power calculation.
This study illustrates that a multifaceted empower-
mentstrategycaneffectivelyencouragetheuseofsingle
embryo transfer in clinical in vitro fertilisation practice.
The strategy increases knowledge and has no substan-
tial effect on levels of anxiety or depression. The
strategy reduces costs as well, and could therefore be
an important tool to reduce the twin rate after in vitro
fertilisation, within a setting with patient autonomy.
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